You have 9 free searches left this month | for more free features.

previously untreated childhood rhabdomyosarcoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma Trial in Worldwide

Completed
  • Adult Rhabdomyosarcoma
  • +3 more
  • conventional surgery
  • +4 more
  • Birmingham, Alabama
  • +162 more
Nov 17, 2021

Sarcoma Trial in New York (biological, drug, procedure, radiation)

Active, not recruiting
  • Sarcoma
  • filgrastim
  • +10 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Nov 5, 2021

Kidney Cancer, Leukemia, Lymphoma Trial in United States (glutamic acid, )

Completed
  • Kidney Cancer
  • +5 more
  • glutamic acid
  • placebo
  • Fort Myers, Florida
  • +5 more
Jul 22, 2021

Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Childhood Alveolar Rhabdomyosarcoma Trial in Worldwide (drug, biological,

Active, not recruiting
  • Adult Malignant Mesenchymoma
  • +10 more
  • Irinotecan Hydrochloride
  • +6 more
  • Birmingham, Alabama
  • +211 more
Dec 9, 2021

Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +9 more
  • DNA analysis
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Oct 28, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +23 more
  • Denver, Colorado
  • +2 more
Jun 17, 2021

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Follicular Lymphoma, Tumor Trial in Houston (Obinutuzumab, CC-99282)

Not yet recruiting
  • Follicular Lymphoma
  • Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Oct 30, 2023

Obinutuzumab-based Therapy for Previously Untreated FL

Recruiting
  • Follicular Lymphoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 3, 2023

Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)

Not yet recruiting
  • Advanced Melanoma
  • IMC-F106C
  • +2 more
  • La Jolla, California
  • +61 more
Oct 31, 2023

Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • (no location specified)
Jul 10, 2023

Follicular Lymphoma Stage II, Follicular Lymphoma Stage III, Follicular Lymphoma Stage IV Trial in Australia (BMS-986369,

Not yet recruiting
  • Follicular Lymphoma Stage II
  • +2 more
  • Ballarat, Victoria, Australia
  • +4 more
Mar 15, 2023

Follicular Lymphoma Trial in Italy (Radiotherapy, Radiotherapy plus Obinotuzumab)

Not yet recruiting
  • Follicular Lymphoma
  • Radiotherapy
  • Radiotherapy plus Obinotuzumab
  • Alessandria, Italy
  • +47 more
Jun 26, 2023

Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Mitoxantrone hydrochloride liposome injection
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 1, 2023

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials

Not yet recruiting
  • Rhabdomyosarcoma
    • San Francisco, California
      Power Life Sciences
    Sep 1, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • (no location specified)
    May 29, 2023

    Non Hodgkin Lymphoma Trial in United Kingdom (R-CHOP + acalabrutinib)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • R-CHOP + acalabrutinib
    • Southampton, Hampshire, United Kingdom
    • +6 more
    Oct 26, 2022

    Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

    Not yet recruiting
    • Pancreatic Cancer Metastatic
    • Pancreatic Adenocarcinoma Metastatic
    • Scottsdale, Arizona
      Clinical Trials Nurse Navigator
    Oct 3, 2023

    Untreated Advanced or Recurrent Thymic Carcinomas Trial in Chuo (MK-3475, Lenvatinib, Carboplatin)

    Not yet recruiting
    • Untreated Advanced or Recurrent Thymic Carcinomas
    • Chuo, Tokyo, Japan
      National Cancer Center Hospital
    Apr 16, 2023

    Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Trial in Worldwide (Acalabrutinib, Venetoclax, Obinutuzumab)

    Recruiting
    • Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    • Tucson, Arizona
    • +40 more
    Dec 20, 2022

    High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

    Recruiting
    • High Grade Myelodysplastic Syndromes
    • Aurora, Colorado
      Universtiy of Colorado Denver
    Nov 17, 2022

    Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • (no location specified)
    Aug 28, 2023

    Familial Investigations of Childhood Cancer Predisposition

    Recruiting
    • Acute Leukemia
    • +45 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      May 11, 2022

      Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

      Not yet recruiting
      • Large B-Cell Lymphoma
      • Xi'an, China
        First Affiliated Hospital of Medical College of Xi'an Jiaotong U
      Sep 14, 2023

      Lymphoma, Mantle Cell Trial in Worldwide (Acalabrutinib, Bendamustine, Rituximab)

      Recruiting
      • Lymphoma, Mantle Cell
      • Downey, California
      • +231 more
      Jan 16, 2023